Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.5 billion.

  • Agilon Health's Cost of Revenue fell 109.37% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 billion, marking a year-over-year increase of 686.27%. This contributed to the annual value of $5.8 billion for FY2024, which is 4574.77% up from last year.
  • As of Q3 2025, Agilon Health's Cost of Revenue stood at $1.5 billion, which was down 109.37% from $1.4 billion recorded in Q2 2025.
  • Agilon Health's 5-year Cost of Revenue high stood at $1.5 billion for Q4 2024, and its period low was $140.3 million during Q4 2021.
  • In the last 5 years, Agilon Health's Cost of Revenue had a median value of $932.8 million in 2023 and averaged $928.4 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 5210.87% in 2021, then surged by 25856.72% in 2023.
  • Over the past 5 years, Agilon Health's Cost of Revenue (Quarter) stood at $140.3 million in 2021, then surged by 129.69% to $322.2 million in 2022, then soared by 258.57% to $1.2 billion in 2023, then surged by 31.44% to $1.5 billion in 2024, then decreased by 1.92% to $1.5 billion in 2025.
  • Its Cost of Revenue was $1.5 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.